Nephrolithiasis and hydronephrosis in an HIV-infected man receiving tenofovir
- PMID: 15325433
- DOI: 10.1016/j.ijantimicag.2004.04.005
Nephrolithiasis and hydronephrosis in an HIV-infected man receiving tenofovir
Abstract
The use of tenofovir as part of a HAART regimen has been widely used in HIV-multi-experienced-patients because of its favourable resistance profile. Tenofovir is mainly eliminated by the kidneys and renal toxicity should be carefully monitored. We describe here the case of an HIV-infected patient, without a prior history of renal failure who developed nephrolithiasis and hydronephrosis after starting a tenofovir-containing HAART regimen.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
